| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.4M | — |
| R&D Expense | $581.1M | +21.8% |
| SG&A Expense | $162.6M | +35.9% |
| Operating Income | -$719.6M | -20.6% |
| Pre-tax Income | -$928.5M | -52.7% |
| Income Tax | $1.3M | +913.2% |
| Net Income | -$929.8M | -52.9% |
| EPS (Basic) | -$1.13 | -29.9% |
| EPS (Diluted) | -$1.13 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.8M | +20.6% |
| Short-term Investments | $1.17B | +59.2% |
| Current Assets | $1.45B | +49.1% |
| Total Assets | $1.80B | +49.2% |
| Current Liabilities | $60.0M | +24.7% |
| Total Liabilities | $385.4M | +32.4% |
| Stockholders' Equity | $1.41B | +54.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$509.9M | -16.9% |
| Capital Expenditures | $53.9M | +32.7% |
| Investing Cash Flow | -$475.4M | -771.8% |
| Financing Cash Flow | $1.03B | +184.3% |
| Free Cash Flow | -$563.8M | -18.2% |
| -29.9% |